Clinical Trials Directory

Trials / Unknown

UnknownNCT01687647

Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure

Interest of Morphometric Analysis of Sputum Cytology for Lung Cancer Screening in Workers Highly Exposed to Asbestos - Exploratory Analysis of Biomarkers Predictive for Lung Cancer

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
56 Years
Healthy volunteers
Not accepted

Summary

Workers exposed to asbestos are at high risk of lung cancer. Medical follow-up of this population relies on repeated CT-scans which are more accurate for detection of peripheral lesions, and expose to X-rays and to risk of false-positives. Analysis of sputum using automate cytometry may be of interest in this population, alone or in combination with CT-scan. An ancillary study will evaluate the interest of blood predictive biomarkers.

Conditions

Interventions

TypeNameDescription
OTHERlow-dose CT-scan AND induced sputum sample AND blood testAll subjects will receive a low-dose CT-scan, a blood test (ancillary study) and provide an induced sputum

Timeline

Start date
2012-09-01
Primary completion
2015-03-01
Completion
2019-12-01
First posted
2012-09-19
Last updated
2014-04-09

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01687647. Inclusion in this directory is not an endorsement.